Expression, Purification and in vitro Activity of Apoptin.

Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai)

Institute of Radiation Medicine, Academy of Military Medical Sciences, Beijing 100850, China.

Published: January 2001

A novel protein named apoptin induces a p53-independent, Bcl-2 insensitive type apoptosis in various human tumor cells but not in normal cells. Apoptin is considered to be a promising candidate for safe and effective anti-tumortherapy. Moreover, apoptin may be important for fundamental studies on molecularbasis of apoptosis and cancer. Apoptin gene was subcloned into prokaryotic expression vector pPROEXHT and pBV220, respectively. The apoptin protein was obtained from pPROEXHT-apoptin expression system and not from pBV220-apoptin the former contains a 6xhistidine affinity tag for ease of purification. Expressed protein was purified by chromatography on a co-chelated affinity column and was renatured by dialysis. The renatured apoptin was able to induce purified Hela nuclei apoptosis in vitro even without the participation of the cytoplasm, showing that apoptin expressed in E.coli was active to induce apoptosis.

Download full-text PDF

Source

Publication Analysis

Top Keywords

apoptin
8
expression purification
4
purification vitro
4
vitro activity
4
activity apoptin
4
apoptin novel
4
novel protein
4
protein named
4
named apoptin
4
apoptin induces
4

Similar Publications

Article Synopsis
  • Apoptin is a promising anticancer protein that selectively induces apoptosis in tumor cells, particularly in breast cancer lines, highlighting its potential for cancer therapy.
  • Researchers successfully created two forms of apoptin fusion proteins (SUMO-PTD4-Apoptin and PTD4-Apoptin) and tested their effects on breast cancer cells (MDA-MB-231 and MCF-7) and normal cells (MCF-10A) using various assays.
  • Results showed that SUMO-PTD4-Apoptin demonstrated a lower IC50 value in cancer cells than in normal cells, indicating higher cytotoxicity, while PTD4-Apoptin had similar effects across both cancer
View Article and Find Full Text PDF

Ad-VT causes ovarian cancer A2780 cell death via mitochondrial apoptosis and autophagy pathways.

Transl Oncol

October 2024

Department of Gynecologic Oncology, First Hospital of Jilin University, Changchun 130021, PR China. Electronic address:

Article Synopsis
  • The study investigates the mechanism of a recombinant adenovirus, Ad-VT, which has a dual action against ovarian cancer cells, specifically targeting apoptosis and autophagy.
  • Using various laboratory techniques, the research demonstrates that Ad-VT significantly inhibits the growth of ovarian cancer cells while sparing normal cells, showing effective tumor suppression in an animal model.
  • The results indicate that Ad-VT primarily induces apoptosis through the endogenous pathway and enhances autophagy in cancer cells, which serves as a protective mechanism against cell death.
View Article and Find Full Text PDF

A novel recombinant adenovirus expressing apoptin and melittin genes kills hepatocellular carcinoma cells and inhibits the growth of ectopic tumor.

Invest New Drugs

August 2024

Key Laboratory of Smart Breeding (Co-construction by Ministry and Province), Ministry of Agriculture and Rural Affairs, Tianjin Agricultural University, Tianjin, 300392, China.

HCC is the most common fatal malignancy. Although surgical resection is the primary treatment strategy, most patients are not eligible for resection due to tumor heterogeneity, underlying liver disease, or comorbidities. Therefore, this study explores the possibility of multi-molecular targeted drug delivery in treating HCC.

View Article and Find Full Text PDF

The emergence of antibiotic resistance prompts exploration of viable antimicrobial peptides (AMPs) designs. The present study explores the antimicrobial prospects of Apoptin nuclear localization sequence (NLS2)-derived peptide ANLP (PRPRTAKRRIRL). Further, we examined the utility of the NLS dimerization strategy for improvement in antimicrobial activity and sustained bio-stability of AMPs.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!